Literature DB >> 22039306

α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation.

Masashi Kanayama1, Junko Morimoto, Yutaka Matsui, Masahiro Ikesue, Keiko Danzaki, Daisuke Kurotaki, Koyu Ito, Toshimichi Yoshida, Toshimitsu Uede.   

Abstract

The interaction between matricellular proteins such as tenascin-C (TN-C) and osteopontin (OPN) and integrins has been implicated in the pathology of rheumatoid arthritis in which Th17 cells are recognized as primary pathogenic cells. The differentiation of Th17 cells is tightly regulated by cytokines derived from APCs, receiving various signals including TLR stimuli. In this study, we used a collagen-induced arthritis model and found that increased numbers of α(9) integrin-positive conventional dendritic cells and macrophage were detectable in the draining lymph node (dLN) shortly following first immunization, and these cells produced both TN-C and OPN, ligands for α(9) integrin. α(9) integrin-mediated signaling, induced by TN-C and OPN, promoted the production of Th17-related cytokines by conventional dendritic cells and macrophages in synergy with TLR2 and 4 signaling. This led to the Th17 cell differentiation and arthritis development. Moreover, Th17 cells generated under blocking of α(9) integrin-mediated signaling showed low level of CCR6 expression and impaired migration ability toward CCL20. Thus, we have identified α(9) integrin-mediated signaling by TN-C and OPN as a novel intrinsic regulator of pathogenic Th17 cell generation that contributes to the development of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039306     DOI: 10.4049/jimmunol.1101524

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing.

Authors:  Chun Chen; Makoto Kudo; Florentine Rutaganira; Hiromi Takano; Candace Lee; Amha Atakilit; Kathryn S Robinett; Toshimitsu Uede; Paul J Wolters; Kevan M Shokat; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

2.  The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Authors:  Shigeyuki Kon; Toshimitsu Uede
Journal:  J Cell Commun Signal       Date:  2017-10-03       Impact factor: 5.782

3.  Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.

Authors:  Shuichi Fujita; Naoshi Shimojo; Fumio Terasaki; Kaoru Otsuka; Noriko Hosotani; Yuka Kohda; Takao Tanaka; Tomohiro Nishioka; Toshimichi Yoshida; Michiaki Hiroe; Yasushi Kitaura; Nobukazu Ishizaka; Kyoko Imanaka-Yoshida
Journal:  Heart Vessels       Date:  2013-01-01       Impact factor: 2.037

Review 4.  Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program.

Authors:  Paula J McKeown-Longo; Paul J Higgins
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

5.  Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts.

Authors:  Daichi Ota; Masashi Kanayama; Yutaka Matsui; Koyu Ito; Naoyoshi Maeda; Goro Kutomi; Koichi Hirata; Toshihiko Torigoe; Noriyuki Sato; Akinori Takaoka; Ann F Chambers; Junko Morimoto; Toshimitsu Uede
Journal:  J Mol Med (Berl)       Date:  2014-08-08       Impact factor: 4.599

Review 6.  Role of osteopontin in rheumatoid arthritis.

Authors:  Fangjie Zhang; Wei Luo; Yusheng Li; Shuguang Gao; Guanghua Lei
Journal:  Rheumatol Int       Date:  2014-08-28       Impact factor: 2.631

Review 7.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

8.  Osteopontin expression by CD103- dendritic cells drives intestinal inflammation.

Authors:  Evangelia Kourepini; Maria Aggelakopoulou; Themis Alissafi; Nikolaos Paschalidis; Davina C M Simoes; Vily Panoutsakopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 9.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  Raised circulating tenascin-C in rheumatoid arthritis.

Authors:  Theresa H Page; Peter J Charles; Anna M Piccinini; Vicky Nicolaidou; Peter C Taylor; Kim S Midwood
Journal:  Arthritis Res Ther       Date:  2012-11-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.